W. Evan Secor

<i>Trichomonas vaginalis</i>Antimicrobial Drug Resistance in 6 US Cities, STD Surveillance Network, 2009–2010

Robert D. Kirkcaldy, Peter Augostini, Lenore Asbel et al. · Emerging infectious diseases · 2012 · 224 citations · Full text

T. Vaginalis Isolates, Antimicrobial Chemotherapy, Std Surveillance Network +23

Studies on Schistosomiasis in Western Kenya: I. Evidence for Immune-Facilitated Excretion of Schistosome Eggs from Patients with Schistosoma mansoni and Human Immunodeficiency Virus Coinfections

Diana M. S. Karanja, Daniel G. Colley, Bernard L. Nahlen et al. · American Journal of Tropical Medicine and Hygiene · 1997 · 210 citations

Schistosoma Mansoni, Parasitic Disease, Epidemiology +15

In Vitro Metronidazole and Tinidazole Activities against Metronidazole- Resistant Strains of <i>Trichomonas vaginalis</i>

Andrea Crowell, Kolby A. Sanders-Lewis, W. Evan Secor · Antimicrobial Agents and Chemotherapy · 2003 · 128 citations · Full text

Antiparasitic Agent, Increased Tinidazole Resistance, Metronidazole- Resistant Strains +16

Trichomonas vaginalis Prevalence, Incidence, Risk Factors and Antibiotic-Resistance in an Adolescent Population

Jamie W. Krashin, Emilia H. Koumans, Ayanna C. Bradshaw-Sydnor et al. · Sexually Transmitted Diseases · 2010 · 117 citations

B-1 cell (CD5+B220+) outgrowth in murine schistosomiasis is genetically restricted and is largely due to activation by polylactosamine sugars

Palanivel Velupillai, W. Evan Secor, Achim Hörauf et al. · The Journal of Immunology · 1997 · 106 citations